Literature DB >> 11388753

CD123 (interleukin 3 receptor alpha chain).

S Moretti1, F Lanza, M Dabusti, A Tieghi, D Campioni, M Dominici, G L Castoldi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388753

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


× No keyword cloud information.
  12 in total

1.  Interleukin-3 receptor α chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy.

Authors:  Wen Du; Juan Li; Wei Liu; Yanli He; Junxia Yao; Yu Liu; Jun Lin; Jine Zheng
Journal:  Tumour Biol       Date:  2015-10-16

2.  Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.

Authors:  Girish Venkataraman; Christine Aguhar; Robert J Kreitman; Constance M Yuan; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2011-10       Impact factor: 2.493

3.  CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.

Authors:  Adhra Al-Mawali; Avinash Daniel Pinto; Shoaib Al-Zadjali
Journal:  Acta Haematol       Date:  2017-10-25       Impact factor: 2.195

Review 4.  T cells expressing CD123 chimeric antigen receptors for treatment of acute myeloid leukemia.

Authors:  Armen Mardiros; Stephen J Forman; Lihua E Budde
Journal:  Curr Opin Hematol       Date:  2015-11       Impact factor: 3.284

5.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis.

Authors:  Sebastian F Schoppmann; Peter Birner; Johannes Stöckl; Romana Kalt; Robert Ullrich; Carola Caucig; Ernst Kriehuber; Katalin Nagy; Kari Alitalo; Dontscho Kerjaschki
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

6.  Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms.

Authors:  Elissandra Machado Arlindo; Natália Aydos Marcondes; Flavo Beno Fernandes; Gustavo Adolpho Moreira Faulhaber
Journal:  Rev Bras Hematol Hemoter       Date:  2017-05-29

Review 7.  Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats.

Authors:  Brent A Williams; Arjun Law; Judit Hunyadkurti; Stephanie Desilets; Jeffrey V Leyton; Armand Keating
Journal:  J Clin Med       Date:  2019-08-20       Impact factor: 4.241

8.  Sjögren's Syndrome: Concerted Triggering of Sicca Conditions.

Authors:  Zygmunt Mackiewicz; Justyna Mażul; Ieva Narkevičiūtė; Irena Dumalakienė; Irena Butrimienė; Rita Vilienė; Indrė Stankevičienė; Diana Mieliauskaitė
Journal:  J Immunol Res       Date:  2019-01-06       Impact factor: 4.818

9.  Differences in IgE mediated basophil degranulation induced by proteic fractions from whole flea body extract in patients with papular urticaria by flea bite and healthy controls.

Authors:  Omar Dominguez-Amorocho; Silvia Duarte; Elizabeth Garcia; Evelyne Halpert; Adriana Cuellar; Adriana Rodriguez
Journal:  World Allergy Organ J       Date:  2013-05-16       Impact factor: 4.084

10.  Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.

Authors:  Adhra Al-Mawali; David Gillis; Ian Lewis
Journal:  J Hematol Oncol       Date:  2016-07-27       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.